SABRINA COFFMAN: Open Payments
NPI 1528406345 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,302 in 73 payments from 19 companies in 2025. Trend: 2023 $1,274 · 2024 $1,273 · 2025 $1,302
Food & beverage: $1,292Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $451 |
| Novo Nordisk Inc | 17 | $277 |
| Otsuka America Pharmaceutical, Inc. | 9 | $176 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Exact Sciences Corporation | 2 | $30 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| PFIZER INC. | 2 | $27 |
| Antares Pharma, Inc. | 1 | $26 |
Products named: QULIPTA, UBRELVY, REXULTI, Rybelsus, Wegovy, Ozempic, VOQUEZNA, Auvelity.
Industry payments across KY — which companies pay providers there.
